Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |